androgen replacement therapy

Also found in: Wikipedia.

androgen replacement therapy

The administration of androgens (e.g., testosterone or its congeners) in men with hypogonadal androgen-deficiency, which may be primary or secondary and either congenital or acquired. The intent of ART is to restore normal physiologic effects of testosterone, which depend on the stage of sexual development.

In androgen-deficient boys, the goal of ART is to initiate and maintain androgen-dependent activities, including somatic development (e.g., development of skeletal muscle and increased strength, long bone growth, redistribution of body fat and erythropoiesis), sexual behaviour (increased libido and potency) and development of 2º sexual characteristics (e.g., male pattern of hair growth, penile and scrotal enlargement, laryngeal enlargement and thickening of the vocal cords, and deepening of the voice).

Androgen replacement therapies 
The oral testosterones available in the US are methyl testosterone and fluoxymesterone; both are nonphysiological, 17-alkylated molecules with hepatotoxic potential.
Well-absorbed physiologic testosterone.

Inconvenience of shaving scrotal skin; impregnation of patches with absorption enhancers, such as alcohol, allows their application to nongenital skin, but causes local irritation in up to 53% of patients.
Absorbed physiologic testosterone.


Sublingual AndroTest-SL®
Convenience; physiologic testosterone.

References in periodicals archive ?
If you or a loved one is considering androgen replacement therapy, talk to a doctor to learn more.
If approved, Natesto will be the first and only testosterone nasal gel for androgen replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone (hypogonadism) in Europe.
Zaman Sheikh gave an Update on Androgen Replacement Therapy.
Androgen replacement therapy (ART) in aging male has given way to much-debated concerns about effects on the prostate.
19] Jin and colleagues have reported significantly lower testosterone and PSA levels in patients who were given androgen replacement therapy for androgen deficiency compared to patients with androgen deficiency who were not given androgen replacement therapy and also compared to healthy men.
Men were classified as treated if they filled a prescription for a phosphodiesterase type-5 (PDE5) inhibitor, injection or urethral prostaglandins, or androgen replacement therapy.
Primary care doctors, rehabilitation doctors, urologists and endocrinologists can order the necessary blood work to determine if testosterone levels are adequate or if androgen replacement therapy might be a consideration.
In view of the emerging evidence suggesting that androgen deficiency is a risk factor for CVD, androgen replacement therapy could potentially reduce CVD risk in hypogonadal men.
Thus, the authors suggest that androgen replacement therapy might one day be used to treat men at risk for heart disease.
Long-term risks of androgen replacement therapy are still unknown, according to Sokol
No androgen replacement therapy is currently approved in the United States for women.
No androgen replacement therapy is approved in the United States for women.

Full browser ?